SeaStar Medical Holding Corporation Market Cap ($8.81 Million)
Market Cap & Net Worth: SeaStar Medical Holding Corporation (ICU)
SeaStar Medical Holding Corporation market cap. SeaStar Medical Holding Corporation (NASDAQ:ICU) has a market capitalization of $8.81 Million ($8.81 Million) as of November 4, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #27265 globally and #5663 in its home market, demonstrating a -19.03% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying SeaStar Medical Holding Corporation's stock price $2.00 by its total outstanding shares 4406841 (4.41 Million). Also see SeaStar Medical Holding Corporation cash flow conversion for how efficiently the company converts equity into cash flow.
SeaStar Medical Holding Corporation Market Cap History (2021–2026)
SeaStar Medical Holding Corporation market cap history from 2021 to 2026. Data shows change from $1.11 Billion to $8.81 Million (-57.41% CAGR). Check ICU share price today for real-time trading data and today's change.
Index Memberships
SeaStar Medical Holding Corporation is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Health Care
IXHC
|
$2.61 Trillion | 0.00% | #767 of 976 |
|
NASDAQ Composite
IXIC
|
$40.20 Trillion | 0.00% | #2497 of 3165 |
Weight: SeaStar Medical Holding Corporation's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
SeaStar Medical Holding Corporation Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how SeaStar Medical Holding Corporation's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore SeaStar Medical Holding Corporation annual equity growth to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
0.86x
SeaStar Medical Holding Corporation's market cap is 0.86 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2024 | $8.55 Million | $135.00K | -$24.83 Million | 63.33x | N/A |
| 2025 | $1.06 Million | $1.23 Million | -$12.15 Million | 0.86x | N/A |
Competitor Companies of ICU by Market Capitalization
Companies near SeaStar Medical Holding Corporation in the global market cap rankings as of November 4, 2026. Also see SeaStar Medical Holding Corporation (ICU) total assets for a full breakdown of the balance sheet.
Key companies related to SeaStar Medical Holding Corporation by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #180 globally with a market cap of $130.90 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #368 globally with a market cap of $76.14 Billion USD.
- CSL Ltd (AU:CSL): Ranked #414 globally with a market cap of $68.22 Billion USD ( AU$96.41 Billion AUD).
- Moderna Inc (NASDAQ:MRNA): Ranked #494 globally with a market cap of $54.14 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #180 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $130.90 Billion | $530.76 |
| #368 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $76.14 Billion | $973.36 |
| #414 | CSL Ltd | AU:CSL | $68.22 Billion | AU$198.72 |
| #494 | Moderna Inc | NASDAQ:MRNA | $54.14 Billion | $228.44 |
Market Capitalization of SeaStar Medical Holding Corporation (2021–2026)
Market capitalization of SeaStar Medical Holding Corporation from 2021 to today. Between 2021 and today, SeaStar Medical Holding Corporation's market cap moved from $1.11 Billion to $ 8.81 Million, with a yearly change of -57.41%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $8.81 Million | +733.33% |
| 2025 | $1.06 Million | -87.63% |
| 2024 | $8.55 Million | -82.48% |
| 2023 | $48.81 Million | -89.20% |
| 2022 | $451.70 Million | -59.16% |
| 2021 | $1.11 Billion | -- |
End of Day Market Cap According to Different Sources
On Nov 4th, 2026 the market cap of SeaStar Medical Holding Corporation was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $8.81 Million USD |
| MoneyControl | $8.81 Million USD |
| MarketWatch | $8.81 Million USD |
| marketcap.company | $8.81 Million USD |
| Reuters | $8.81 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About SeaStar Medical Holding Corporation
SeaStar Medical Holding Corporation, a commercial-stage healthcare company, develops a proprietary platform therapy to reduce the consequences of hyperinflammation on vital organs in the United States. The company offers the selective cytopheretic device (SCD), which is a disease-modifying device that neutralizes over-active immune cells and stops the cytokine storm that yields destructive hyperi… Read more